Navigation Links
Zogenix and Desitin Announce Filing for European Regulatory Approval of SUMAVEL(TM) DosePro(TM)
Date:10/28/2009

SAN DIEGO and HAMBURG, Germany, Oct. 28 /PRNewswire/ -- Zogenix, Inc. ("Zogenix"), a privately held pharmaceutical company, and Desitin Pharmaceuticals GmbH ("Desitin"), a privately held, mid-sized German pharmaceutical company, today announced that Desitin has filed for European regulatory approval of SUMAVEL DosePro (sumatriptan injection) needle-free delivery system. The announcement follows successful completion of a European pivotal bioequivalence trial comparing needle-free SUMAVEL DosePro to a traditional needle-based autoinjector, Imigran®-Inject, the European brand of Imitrex STATdose System®. In March 2008, Zogenix and Desitin entered into a license agreement granting exclusive rights in the European Union to Desitin Pharmaceuticals GmbH ("Desitin") to develop and commercialize SUMAVEL DosePro.

SUMAVEL DosePro was recently approved by the U.S. FDA to treat acute migraine, with or without aura, and cluster headache, and will be launched by Zogenix in the U.S. in January 2010. SUMAVEL DosePro is a first-of-its-kind needle-free delivery system for subcutaneous sumatriptan, a treatment that provides migraine relief within 10 minutes for some patients. In clinical trials, the drug was shown to be absorbed rapidly, resulting in peak plasma concentrations within approximately 12 minutes. This rate of absorption of subcutaneous sumatriptan has been shown to correlate with rapid and complete relief of migraine symptoms, including migraine relief within 10 minutes for some patients and within 30 minutes for almost 50% of patients. Overall safety profiles were comparable for SUMAVEL DosePro and Imitrex STATdose System®.

"This filing demonstrates Desitin's ability to move this product candidate through development and into the European regulatory approval process," commented Dr. Martin Zentgraf, Desitin's General Manager. "Subject to regulatory approval, we look forward to launching it with our CNS-focused sales repr
'/>"/>

SOURCE Zogenix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Zogenix and Astellas Enter Exclusive Co-Promotion Agreement in the US for Newly Approved Sumavel(TM) DosePro(TM)
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... West Palm Beach, Florida (PRWEB) September 30, 2014 ... of Florida make the treatment of gum disease ... traditional treatments of the past. , “If you’ve ever felt ... into ice cream or sip a cold beverage, it’s possible ... Herbert Salisbury , who is a general dentist in ...
(Date:9/30/2014)... (HealthDay News) -- Medicare should cover low-dose computed tomography ... the disease, a coalition of more than 60 patient ... the Lung Cancer Alliance, the Society of Thoracic Surgeons, ... and the American Society of Clinical Oncology, made its ... Centers for Medicare & Medicaid Services (CMS). Such ...
(Date:9/30/2014)... made progress in reducing the stigma associated with seeking ... stress disorder, but more improvement is still needed, according ... of both the Defense Department and the Veterans Health ... still do not seek needed care for mental ... to promote treatment as a way to reduce stigma, ...
(Date:9/30/2014)... a gene mutation that causes a rare premature aging ... block the rapid, unstoppable cell division that makes cancer ... Michigan and the U-M Health System recently discovered a ... in which precious hematopoietic stem cells can,t regenerate and ... are prone to cancer and bone marrow failure. ...
(Date:9/30/2014)... FDA-approved injectable dermal fillers (i.e. hyaluronic ... in several procedures that are performed to restore ... primarily used for wrinkle treatment of the skin, ... are being used as popular treatments in nonsurgical ... the hands. (1) (2) Dr. Cynthia Elliott of ...
Breaking Medicine News(10 mins):Health News:Florida Dentist Battles Gum Disease With Latest Techniques 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 3Health News:Groups Call for Medicare Coverage of Lung Cancer Screening 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 2Health News:US military making progress reducing stigma tied to seeking help for mental illness 3Health News:Disease decoded: Gene mutation may lead to development of new cancer drugs 2Health News:Nonsurgical Cosmetic How-To: Skinspirations Details Proper Use of FDA-Approved Injectable Fillers for Hand Rejuvenation Procedures 2Health News:Nonsurgical Cosmetic How-To: Skinspirations Details Proper Use of FDA-Approved Injectable Fillers for Hand Rejuvenation Procedures 3Health News:Nonsurgical Cosmetic How-To: Skinspirations Details Proper Use of FDA-Approved Injectable Fillers for Hand Rejuvenation Procedures 4
... Hopkins Kimmel Cancer Center researchers say preliminary studies show ... able to reduce or eliminate the last remaining cancer ... the drug Imatinib mesylate (Gleevec). Gleevec, one of ... CML patients, destroys most leukemic cells in the body, ...
... new study, scientists have searched for mutations in the gene regions ... samples from a single tumour type to be sequenced to date. ... type of kidney cancer, with 102,000 deaths worldwide each year. It ... its nature is remarkably consistent and the majority of cases ...
... arthritis (RA) patients are partially protected by the influenza ... determined that while the flu vaccine is safe, it ... months following rituximab treatment. Previous influenza vaccination in ... some defense to influenza strains. RA activity was ...
... /CNW/ - A recent evaluation by the Centre for Addiction ... alcohol use can be effective in changing drinking behaviours and ... first evaluation of its kind, the study published in ... online screener www.CheckYourDrinking.net, reduced their alcohol consumption by 30% - ...
... of mental health professionals, emergency response experts, and researchers ... results of a study that shows serious emotional disturbances ... Category 3 storm ravaged the Gulf Coast in August ... of the Journal of the American Academy of ...
... the US population becomes increasingly obese while smoking rates continue ... contributor to the burden of disease and shortening of healthy ... the February 2010 issue of the American Journal of ... College of New York calculate that the Quality-Adjusted Life Years ...
Cached Medicine News:Health News:Johns Hopkins researchers say vaccine appears to 'mop up' leukemia cells Gleevec leaves behind 2Health News:Unraveling kidney cancer 2Health News:Unraveling kidney cancer 3Health News:Efficacy of flu vaccine drastically reduced for RA patients treated with rituximab 2Health News:Technology new gateway into treatment for problem alcohol users: Study 2Health News:Obesity now poses as great a threat to quality of life as smoking 2
(Date:9/30/2014)... , Sept. 30, 2014  HealthLoop® released an app ... HealthKit in iOS 8 and allows people to share ... app harnesses native iOS technologies to enhance the HealthLoop ... robust connection with their doctors between visits. ... the data they collect is exciting," says HealthLoop founder ...
(Date:9/30/2014)... Sept. 30, 2014  Proteomics is a focus ... new report from Kalorama Information.  The healthcare market research ... in proteomics in the past two years.  The ... between private proteomic companies and academic institutions, to ... proteomics innovator companies.  Kalorama observed the industry in ...
(Date:9/30/2014)... SAN DIEGO , 30. September ... Logo - http://photos.prnewswire.com/prnh/20130430/LA01948LOGO ... ein Medizintechnikunternehmen, das ein minimal-invasives 3D-Herzkammer-Bildgebungs- ... der Ursachen entwickelt, die zu komplexen ... aufrechterhalten, hat den Abschluss einer zusätzlichen ...
Breaking Medicine Technology:HealthLoop Integrates with Apple's HealthKit Enabling Patients to Share Health Data with Their Doctors Right from their iPhone 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 3Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 2Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 3
... DEERFIELD, Ill., and LONDON, Aug. 16 Baxter,International ... Baxter,s European,subsidiary in the United Kingdom has entered ... Health that contains an option to purchase,pandemic influenza ... (WHO),declares a pandemic. Baxter will manufacture its ...
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) a ... proprietary product candidates for the treatment,of cancer ... U.S. Food and,Drug Administration (FDA) has granted ... which is currently being investigated in a,pivotal ...
Cached Medicine Technology:Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health 2Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health 3ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer 2ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer 3
... oxygen flowmeters., ,Options: , ... S to model number. Example: ... add suffix C to model ... Double Flowmeters with Power Take-Off, ...
... flowmeters., ,Options: , For ... to model number. Example: FMC107S. ... suffix C to model number. ... Flowmeters with Power Take-Off, add ...
... Slim Line Flowmeters with brass and ... security chain, add suffix S to ... Canadian Color-Code, add suffix C to ... Double Flowmeters with Power Take-Off, add ...
... Flowmeters with brass and aluminum body., ... add suffix S to model number. ... add suffix C to model number. ... with Power Take-Off, add PT to ...
Medicine Products: